An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA

PHASE3CompletedINTERVENTIONAL
Enrollment

854

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

October 22, 2019

Study Completion Date

October 22, 2019

Conditions
Knee Osteoarthritis
Interventions
DRUG

CNTX-4975-05

Osteoarthritis (OA) intra-articular injection of CNTX-4975-05

DRUG

Lidocaine without epinephrine

15 mL lidocaine intra-articular injection

DEVICE

ElastoGel

Cooling Device

DEVICE

Breg Ice Water Pump

Cooling Device

Trial Locations (28)

30060

Georgia Institute for Clinical Research, LLC, Marietta

30281

Atlanta Orthopaedic Institute, LLC, Stockbridge

32751

Conquest Clinical Research, Maitland

32757

Charter Research, Mt. Dora

33184

F&T Medical Research, Inc., Miami

33185

M&M Medical Center, Inc., Miami

33351

M&M Clinical Trials Sunrise, Sunrise

33781

Ascension Research, Pinellas Park

34761

Premier MED Family & Sports Medicine, Ocoee

35209

Alabama Orthopaedic Center-Research, Birmingham

47714

MediSphere Medical Research Center, LLC, Evansville

60422

Healthcare Research Network II, LLC, Flossmoor

60523

Affinity Health, Oak Brook

63042

Healthcare Research Network, Hazelwood

64114

Center for Pharmaceutical Research, LLC, Kansas City

70072

Tandem Clinical Research, Marrero

70115

DelRicht Research, New Orleans

75231

Metroplex Clinical Research Center, Dallas

77004

Hermann Drive Surgical Hospital, Houston

77401

First Surgical Hospital, Bellaire

85381

Holland Center for Family Health, Peoria

85704

Noble Clinical Research, Tucson

89119

Office of Robert P. Kaplan, DO, Las Vegas

90703

Core Healthcare Group, Cerritos

91978

Encompass Clinical Research, Spring Valley

95608

Med Center Medical Clinic, Carmichael

06708

Chase Medical Research, LLC, Waterbury

08009

Hassman Research Institute, Berlin

Sponsors
All Listed Sponsors
lead

Centrexion Therapeutics

INDUSTRY